Molecular Analysis for Personalised therapy (MAP) 2017

Country: Switzerland

City: Zurich

Abstr. due: 04.08.2017

Dates: 13.10.17 — 14.10.17

Area Of Sciences: Biology; Medicine;

Organizing comittee e-mail:

Organizers: European Association for Cancer Research


We are pleased to announce the 3rd edition of the MAP meeting; a joint initiative of ESMO, UNICANCER and Cancer Research UK. MAP will continue to explore and discuss the clinical interpretation of molecular analysis for metastatic cancers alongside medical oncologists, researchers, onco-geneticians, clinical investigators, molecular biologists, cytopathologists, radiotherapists, fellows, academics, regulators and industry R&D.

Topics include:

  • Macroevolution and impact on treatment resistance
  • New models and technologies for personalised medicine
  • Personalised medicine applied to immunotherapeutics
  • Therapeutic targets in cancer
  • Treatment advances in central nervous system tumours
  • Tumour microenvironment and treatment resistance
  • Understanding the broader tumour microenvironment

Young Oncologist Grants: Young oncologists under 40 years old who present an abstract are eligible to apply for a travel grant.

Conference Web-Site: